Skip to main content
Erschienen in: Osteoporosis International 5/2013

01.05.2013 | Original Article

Tooth extraction in osteoporotic patients taking oral bisphosphonates

verfasst von: M. Mozzati, V. Arata, G. Gallesio

Erschienen in: Osteoporosis International | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Summary

This prospective study compares two different surgical protocols with different degrees of invasiveness for tooth extraction in patients treated with oral bisphosphonates (BPs). No intraoperative complications were observed in either of the two groups, and there was no evidence of postoperative bisphosphonate-associated osteonecrosis of the jaw in any of the extractions in the study group at follow-up (1,480 extractions). According to our data, dental extraction seems to be safe in osteoporotic patients treated with oral bisphosphonates.

Introduction

Oral bisphosphonates are drugs commonly prescribed for the treatment of osteoporosis and other resorptive bone diseases. Since 2003, there have been numerous publications relating bisphosphonate-related osteonecrosis of the jaw (BRONJ) in patients using oral bisphosphonates, such as alendronate and risedronate. Most of the BRONJ cases reported in literature show a strong correlation with dental pathologies, dental extractions, and/or oral surgical procedures.

Methods

This study was conducted on 700 consecutive patients treated with oral bisphosphonates who underwent dental extractions. A total of 1,480 extractions were involved: 864 in the mandible and 616 in the maxilla. The patients were assigned randomly to one of two groups: 334 were treated with delicate surgery and closure by primary intention (Protocol A), and the other 366 were treated with nontraumatic avulsion and closure by secondary intention (Protocol B). All patients were administered with antibiotics coverage.

Results

Seven hundred patients with required removal of compromised teeth were included in the study. No intraoperative complications were observed in either of the two groups, and there was no evidence of postoperative bisphosphonate-associated osteonecrosis of the jaw in any of the extractions in the study group at follow-up (1,480 extractions).

Conclusions

The findings of this prospective study indicate that both suggested protocols for tooth extraction in patients treated with oral BPs can provide a predictable treatment outcome (100 % success). Therefore, because atraumatic surgery is more comfortable for patients, we suggest the adoption of Protocol B, which limits trauma to both the soft and hard tissues.
Literatur
1.
Zurück zum Zitat Boskey AL, Coleman R (2012) Aging and bone. J Dent Res 89(12):1333–1348 Boskey AL, Coleman R (2012) Aging and bone. J Dent Res 89(12):1333–1348
2.
Zurück zum Zitat Banks E, Reeves GK, Beral V, Balkwill A, lIu B, Roddam A (2009) Hip fracture incidence in relation to age, menopausal status and age at menopause: prospective analysis. PLoS Med 6:e1000181PubMedCrossRef Banks E, Reeves GK, Beral V, Balkwill A, lIu B, Roddam A (2009) Hip fracture incidence in relation to age, menopausal status and age at menopause: prospective analysis. PLoS Med 6:e1000181PubMedCrossRef
3.
Zurück zum Zitat Ruggiero SL (2007) Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Case Miner Bone Metab 4(19):37–42 Ruggiero SL (2007) Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Case Miner Bone Metab 4(19):37–42
4.
Zurück zum Zitat Wells G, Cranney A, Peterson J et al (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23:1 Wells G, Cranney A, Peterson J et al (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 23:1
5.
Zurück zum Zitat Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef
6.
Zurück zum Zitat Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21(22):4253–4254PubMedCrossRef Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21(22):4253–4254PubMedCrossRef
7.
Zurück zum Zitat Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826–836PubMedCrossRef Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M et al (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23:826–836PubMedCrossRef
9.
Zurück zum Zitat Park W, Kim NK, Kim MY et al (2010) Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int 21(3):535–536CrossRef Park W, Kim NK, Kim MY et al (2010) Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases. Osteoporos Int 21(3):535–536CrossRef
10.
Zurück zum Zitat American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137:1144–1150 American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 137:1144–1150
11.
Zurück zum Zitat Wynn RL (2007) Oral bisphosphonates and osteonecrosis of the jaw. Gen Dent 55:8PubMed Wynn RL (2007) Oral bisphosphonates and osteonecrosis of the jaw. Gen Dent 55:8PubMed
12.
Zurück zum Zitat Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention and treatment. J Oral Maxillofac Surg 65:2397–2410PubMedCrossRef Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention and treatment. J Oral Maxillofac Surg 65:2397–2410PubMedCrossRef
13.
Zurück zum Zitat Etiminan M, Aminzadek K, Matthew ER et al (2008) Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nasted case–control study. J Rheumatol 35:3 Etiminan M, Aminzadek K, Matthew ER et al (2008) Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nasted case–control study. J Rheumatol 35:3
14.
Zurück zum Zitat Yarom R, Yahalom Y et al (2007) Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, features, predisposing factors and treatment outcome. Osteoporos Int 18:1363–1370PubMedCrossRef Yarom R, Yahalom Y et al (2007) Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, features, predisposing factors and treatment outcome. Osteoporos Int 18:1363–1370PubMedCrossRef
15.
Zurück zum Zitat Pazianas M, Miller P, Blumentals WA et al (2007) A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors and clinical characteristics. Clint her 29:1548–1558 Pazianas M, Miller P, Blumentals WA et al (2007) A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors and clinical characteristics. Clint her 29:1548–1558
16.
Zurück zum Zitat Woo SB, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753PubMedCrossRef Woo SB, Hellstein JW, Kalmar JR (2006) Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753PubMedCrossRef
17.
Zurück zum Zitat Van den Wyngaert T, Huizing MT, Vermorken JB (2006) Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Ann Oncol 17:1197–1204PubMedCrossRef Van den Wyngaert T, Huizing MT, Vermorken JB (2006) Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Ann Oncol 17:1197–1204PubMedCrossRef
18.
Zurück zum Zitat Wilde F, Heufelder M, Winter K et al (2010) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153–163PubMed Wilde F, Heufelder M, Winter K et al (2010) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(2):153–163PubMed
19.
Zurück zum Zitat Advisory Task force on bisphosphonate-related osteonecrosis of the jaws (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65(3):369–376CrossRef Advisory Task force on bisphosphonate-related osteonecrosis of the jaws (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65(3):369–376CrossRef
20.
Zurück zum Zitat Nase JB, Suzuki JB (2006) Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc 137:1115–1119PubMed Nase JB, Suzuki JB (2006) Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc 137:1115–1119PubMed
21.
Zurück zum Zitat Assael LA (2007) Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk? J Oral Maxillofac Surg 65:2395–2396PubMedCrossRef Assael LA (2007) Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk? J Oral Maxillofac Surg 65:2395–2396PubMedCrossRef
22.
Zurück zum Zitat Favia G, Pilolli GP, Maiorano E (2009) Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol 36(12):2780–2787PubMedCrossRef Favia G, Pilolli GP, Maiorano E (2009) Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. J Rheumatol 36(12):2780–2787PubMedCrossRef
23.
Zurück zum Zitat Edwards BJ, Hellstein JW, Jacobsen PL et al (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139:1674–1677PubMed Edwards BJ, Hellstein JW, Jacobsen PL et al (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139:1674–1677PubMed
24.
Zurück zum Zitat Malden N, Beltes C, Lopes V (2009) Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Br Dent J 206:93–98PubMedCrossRef Malden N, Beltes C, Lopes V (2009) Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm. Br Dent J 206:93–98PubMedCrossRef
25.
Zurück zum Zitat Regev E, Lustmann J, Nashef R (2008) Atraumatic teeth extraction in bisphosphonate-treated patients. J Oral Maxillofac Surg 66:1157–1161PubMedCrossRef Regev E, Lustmann J, Nashef R (2008) Atraumatic teeth extraction in bisphosphonate-treated patients. J Oral Maxillofac Surg 66:1157–1161PubMedCrossRef
26.
Zurück zum Zitat Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D (2012) Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis 18(1):85–95PubMedCrossRef Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D (2012) Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis 18(1):85–95PubMedCrossRef
27.
Zurück zum Zitat Mozzati M, Arata V, Gallesio G, Carossa S (2011) Tooth extraction and oral bisphosphonates: comparison of different surgical protocols. J Bone Spine 78(6):647–648CrossRef Mozzati M, Arata V, Gallesio G, Carossa S (2011) Tooth extraction and oral bisphosphonates: comparison of different surgical protocols. J Bone Spine 78(6):647–648CrossRef
Metadaten
Titel
Tooth extraction in osteoporotic patients taking oral bisphosphonates
verfasst von
M. Mozzati
V. Arata
G. Gallesio
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 5/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-2239-8

Weitere Artikel der Ausgabe 5/2013

Osteoporosis International 5/2013 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.